Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
In 2022, the fifth series of the AFIP Atlases of Tumor and Non-Tumor Pathology expanded on the second edition of the Atlas of Non-Neoplastic Disorders of the Endocrine System [1] by our esteemed colleagues Drs. Anthony J. Gill, Lori A. Erickson and Talia L. Fuchs (Fig. 1). This edition is bult on the timeless foundation of the first edition that was co-authored by Drs. Lloyd, Douglas and Young in 2002. Dr. Christofer C. Juhlin also served as an independent scientific reviewer for the manuscript of this fascicle (Karolinska Institute, Stockholm, Sweden).
Fig. 1
The cover of the Atlas of the Non-Neoplastic Disorders of the Endocrine Systems by Drs. Gill, Erickson and Fuchs
CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.
FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?